贝伐单抗靶向治疗结直肠癌的临床研究进展
摘要
Molecular targeted therapy is currently the most effective method for the treatment of colorectal cancer. With the wide application of molecular targeted therapy, people began to focus on bevacizumab in the treatment of colorectal cancer, and in recent years, it was found that the targeted therapy of bevacizumab can better treat colorectal cancer, so it has become the main drug in the treatment of colorectal cancer. In order to better use this drug, this paper analyzed the specific effects of bevacizumab in targeted treatment of colorectal cancer, discussed its mechanism of action and application principle, and discussed its clinical application.
引用本文（GB/T 7714）
香莲 吴. 贝伐单抗靶向治疗结直肠癌的临床研究进展[J]. 亚洲临床医学杂志, 2021.
引文网络
本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。